Ayaan Parikh

dropped out of Stanford CS to build Convexia (yc s25)

[entropy.io @entropyIO]

We are releasing the first liquid way to trade Anthropic.

For far too long, frontier assets have only been accessible to a select few. We are here to bring them to the masses.

Introducing EntropyIO. We’ve raised $14M led by Ribbit Capital and a $40M HYPE stake to build both improved and entirely new markets, the first of which are live on Hyperliquid today.

[Ayaan Parikh @AyaanParikh]

@agupta Hmm sounds familiar 🫣 maybe go to Taiwan and South Korea too

[Ayaan Parikh @AyaanParikh]

@RudyResearch EVO756’s needs a very large true delta versus placebo to win Phase 2b because 1) placebo causes big UAS7 drops, and 2) incremental benefit over anti-histamines. Plus the fact that INCY is not releasing their partial data nor advancing a backup suggests they saw nothing.

[Tanmay @tkejr_]

"Any hyper-competitive person knows that the fear of stagnation hurts 10x more than any win satisfies. Winning is just a brief reprieve from the threat of losing."

- @AyaanParikh

[Ayaan Parikh @AyaanParikh]

@owl_posting Couldn’t ask for a better comparison

[Ayaan Parikh @AyaanParikh]

@ronalfa @owl_posting Don’t forget the part where we also predict the entire clinical trial 😉

[Ayaan Parikh @AyaanParikh]

@ArtirKel @owl_posting Coming soon…

[owl @owl_posting]

extremely excited to discover that biotech has its first cluely company

[Ayaan Parikh @AyaanParikh]

@tariq_manaal Cortellis, GlobalData, Patsnap, and Pharmaprojects

[Ayaan Parikh @AyaanParikh]

A GLP-1 goldmine: shelved incretins with ≥7 years of IP runway in China, Japan, and S Korea.

We just found several oral GLP-1s that fit this profile. We’re giving one away (maybe a billion-dollar mistake).

[email protected] if you are interested to see what else we can do.

[Ayaan Parikh @AyaanParikh]

@Tagrtagr Really hot space rn, amazing to see cool projects like this

[Y Combinator @ycombinator]

Convexia (https://t.co/DFqZxH2ava) is an AI-maximalist pharma company. They buy drugs, run clinical trials on them, and then sell them for profit.

Congrats on the launch, @AyaanParikh and @RahulVijayan30!

https://t.co/CvpDkiJyWh

[Ayaan Parikh @AyaanParikh]

@MAliyanIshfaq @_NajamTariq Wow, excited to test this out. Great work.